Smoking history and cessation discussions in cancer patients receiving definitive radiotherapy: Do we treat all patients equally?

INTRODUCTION: Tobacco is recognized as a causative agent for head and neck (H&N) and lung cancers, but not for cancers of the prostate or breast. Still, tobacco use during radiotherapy has been associated with poorer outcomes for all four of these commonly treated malignancies. We sought to eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Holland, John M., Holland, Emily, Chen, Yiyi, Brown, Simon A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Publishing on behalf of the European Network for Smoking and Tobacco Prevention (ENSP) 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398132/
https://www.ncbi.nlm.nih.gov/pubmed/32760866
http://dx.doi.org/10.18332/tpc/120308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398132/
https://www.ncbi.nlm.nih.gov/pubmed/32760866
http://dx.doi.org/10.18332/tpc/120308

Ejemplares similares